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Members of the tumor necrosis factor 
(TNF) superfamiliy are potent regulators 
of inflammation  and cell survival and 
consist of 20 ligands that signal through 




Signal transduction/pathway activation 
NF-κB can, non-can, MAPK 
Inflammation, Cell growth, angiogenesis 






Tweak (Tumor necrosis factor like weak inducer of apoptosis) 
TWEAK is a widely expressed cytokine 
 
Chicheportiche et al.. JBC 19 (1997), 32401–32410, 
 
Fn14 is expressed by many cell types including epithelial, 
mesenchymal and endothelial cells, as well as neurons, 
astrocytes etc.. 
Fn14 gene expression is highly regulated both in vitro and in 
vivo. 
Fn14 is expressed at low levels in normal tissues and 
significantly higher levels of expression have been noted in 
multiple tumor specimens. 
 
Background 
Wiley, J.A. Winkles / Cytokine & Growth Factor Reviews 14 (2003), 241–249 
Background 
Pathogenic role of TWEAK in human diseases 
TWEAK-dependent Fn14 signaling can contribute to the 
clinical severity of autoimmune inflammatory diseases: 
rheumatoid arthritis, SLE (lupus nephritis), multiple 
sclerosis, atopic dermatitis, autoimmune encephalomyelitis. 
Others: 
chronic renal failure: Kidney injury 
Cancer: prostate cancer, renal carcinomas, breast tumors, 
esophageal adenocarcinoma, endometrial cancer, Glial 
tumors   
Ulcerative collitis 
Periodontitis 
Cardivascular component (Heart failure, cardiomyopathy, 
atherosclerosis, abdominal aortic aneurysm, non-dialysis 
Chronic Kidney Disease, pulmonary artery hypertension 
and acute myocardial infarction. 




Autoimmune disease  
 rheumatoid arthritis 
  SLE  
 multiple sclerosis 
Background 
Tweak circulating levels as potential biomarker 
Cardivascular component  
 Heart failure  
 Cardiomyopathy 
 Atherosclerosis 
 Abdominal aortic aneurysm 
 Non-dialysis chronic kidney disease  
 Pulmonary artery hypertension  
 Acute myocardial infarction 
TWEAK/Fn14 IN OBESITY 
Table 1.  
Clinical and anthropometrical characteristics of the studied cohorts 
 






















Age (years) 51.7  16.0 57.1  15.0 57.4  12.8 ns 61.6  10.6 66.1  8.6 ns 44.58.3 400.4 ns 
Gender (n, 
male/female) 
13/6 16/12 9/6 ns 21/15 5/6 ns 23/12 9/14 ns 
BMI (kg/m2) 23.6 (24.2) 27.2 (27.9) 32.1 (33.6) <0.001 28.6 (31.5) 28.7 (30.4) ns 26.23.6 57.47.3 <0.001 
Waist circumference 
(cm) 
83.0 (90.0) 97.0 (100.0) 107.0 (117.2) <0.001 100.0 (107.0) 97.0 (102.0) ns 90.813 146.223.5 <0.001 
FFA (mM) 0.8 (1.2) 0.7 (0.9) 0.8 (1.0) ns 0.8  0.3 0.9  0.4 ns 0.90.5 0.60.4 ns 
Cholesterol (mM) 5.2  1.2 4.9  1.0 5.2  0.8 ns 5.1  0.9 4.7  1.2 ns 4.8 (5.6) 5.2 (5.5) ns 
HDL-chol (mM) 1.5  0.5 1.3  0.3 1.4  0.3 ns 1.4 (1.6) 1.2 (1.9) ns 1.3 (1.5) 1 (1.5) ns 
Triglycerides (mM) 1.0 (1.6) 1.1 (1.5) 1.0 (1.3) ns 1.0 (1.5) 1.7 (2.3)  <0.001 0.9 (1.5) 1.2 (1.6) ns 
Glucose (mM) 4.8  0.7 5.5  0.5a 5.6  0.5b <0.001 5.6 (5.8) 8.3 (10.1) <0.001 5 (5.7) 5.4 (6.1) ns 
Insulin (μIU/ml) 3.4 (6.7) 4.0 (7.2) 6.6 (16.5) ns 4.5 (7.7) 10.2 (21.4) ns 4 (7.6) 23 (51) <0.001 
HOMA-IR 0.75 (1.83) 1.01 (2.09) 1.60 (4.79)  0.028 1.22 (2.10) 3.66 (23.66)  <0.001 1 (2) 5.4 (13) <0.001 
sIL-6 (pg/ml) 1.4 (2.5) 1.0 (2.2) 2.5 (5.2)  0.022 1.4 (2.6) 1.5 (2.4)  ns 1.3 (2.6) 5.5 (8.9) <0.001 
           
 
a
 Differences vs lean 
b 
Differences vs overweight 
ns: not significant 
ND: not determined 
Chacón et al. Cytokine 2006, 33 129-37 
Vendrell et al. JCEM. 2010; 95:2983-92 
1. Selected Cohorts 
500mg 
RNA isolation by RNAsy®  
Mini Kit (Qiagen) 
Measured  gene expression 
TWEAK and Fn14 
SAT and VAT 
Applied Biosystems Fast Real Time 
Table 2 
Differential expression levels of TWEAK and Fn14 in the studied cohorts (A). Depot specific analysis (B) 
A. 
 






















Gene expression levels (arbitrary units) 
SAT TWEAK 0.94±0.21 1.06±0.22 0.92±0.33 ns 1.01 0.3 1.160.3 ns 0.980.3 1.350.43 0.001 
VAT TWEAK 0.80±0.18 0.90±0.18 0.89±0.38 ns 0.890.25 0.891.16 ns 0.870.2 1.340.7 0.004 
SAT Fn14 0.78±0.46 0.67±0.30 0.93±0.53 ns 0.80.4 1.61.3 ns 0.64 (1.03) 2.6 (13.3) <0.001 





































Vendrell et al. JCEM. 2010; 95:2983-92 
2. TWEAK/Fn14 expression study in SAT-VAT paired samples 
What is inducing the over-expression of Tweak/Fn14 in severely obese subjects? 
‘hypoxia hypothesis’ suggested that the 
dysregulation of the production of 
inflammation-related adipokines in 
obesity, linked to the development of the 
metabolic syndrome and other obesity-
associated disorders, is a specific response 
to relative hypoxia in clusters of adipocytes 
that become distant from the vasculature as 
adipose tissue mass expands (Trayhurn P & 
Wood IS Br J Nutr (2008) 92, 347–355) 
endoplasmic reticulum (ER) 
stress In the transformation of a 
healthy functional adipocyte to a 
hypertrophic, dysfunctional 
adipocyte, mitochondrial function is 
lost, and multiple stress-signaling 
cascades are initiated from the ER 
(Hotamisligil GS. Cell. (2010) 140,900-17).  





























Gene  Function Reference 
VISFATIN Pro-inflammatory and potentially 
insulin-mimetic adipokine.   HIF-1 
hypoxia regulated gene. 
Segawa et al. 
2006 
FIAF Lipid metabolism.  Highly up-regulated 
during hypoxia 
Kersten, 2005 
HIF-1α Key transcription factor in hypoxia Frede et al., 2007 
HYOU1 Oxygen-regulated protein (150 kDa) 
has been reported to be linked to type 2 
diabetes and obesity. 
Kovacs et al., 
2002 
GLUT1 Glucose transporter 1 gene in human 
adipocytes. It has been found to be 
increased under hypoxia. 
Wood et al., 
2007 
VEGF Mediator of inflammation and an 
angiogenic factor and it is hypoxia 
regulated. 
Jiang et al., 2006 
GRP78 Protein strongly related with glucose 
metabolism and ER stress. 
Hosogay et al., 
2007 
XBP-1 Transcription factor that modulates the 
ER stress response. 
























Selected candidate genes 
Table 3 
Gene expression analysis of hypoxia and ER genes in SAT and VAT samples in obesity (arbitrary units) 
  











Depot SAT VAT SAT VAT SAT VAT SAT VAT SAT VAT 
Adipokynes 
VISFATIN 1.2 (2.7) 0.8 (1.3) 0.9 (1.4) 0.8 (1.1) 1 (1.9) 0.8 (1.1) 1.2 (2.5) 0.9 (1.3) 1.6 (7.2)* 6.6 (27.8)*# 
Hypoxia 
FIAF 2±0.9# 1.1±0.6 1.8±0.6# 0.9±0.6 1.5±0.5 1.3±0.9 1.70.72# 1.140.7 2.81.54* 1.81.34*# 
HIF-1α 0.9 (19 1 (1.2) 0.9 (1) 0.9 (1) 1 (1.3) 1 (1.3) 0.9 (1.1) 1 (1.3)# 1.8 (4.5)* 3.2 (5.3)*# 
HYOU1 0.8±0.2 1±0.2# 0.9±0.1 0.9±0.2 0.9±0.2 0.9±0.1 0.8 (1) 0.9 (1) 1.4 (1.6)* 1.4 (1.7)* 
GLUT1 1 (1.8) 1.6 (2.3)# 0.9 (1.2) 1.1 (1.6)# 0.9 (1.2) 1.3 (1.7) 1 (1.1) 1.1 (1.7)# 2.8 (4.8) 5.1 (9.4)*# 
VEGF 1.4 (2)* 1.5 (1.7)* 1 (1.3) 1 (1.5) 1 (1.5) 1 (1.2) 1.3 (1.8) 1.2 (1.5) 2.5 (4.3)* 6.5 (9)*# 
ER stress 
GRP78 0.9±0.2 1.1±0.2# 0.8±0.1 1±0.3# 0.9±0.3 1±0.2 0.90.2 10.2# 1.40.6* 1.81* 
XBP-1 0.8±0.2 1±0.3# 0.8±0.1 1±0.2# 0.8±0.2 0.8±0.1 0.80.2 10.3# 0.90.5* 1.60.9*# 
*differences when comparing same depot between obesity group study p<0.05 
#




Have our studied subjects altered the expression of hypoxia and ER regulated  
genes? 
Vendrell et al. JCEM. 2010; 95:2983-92 
Study of effect of hypoxia, inflammation and ER stress on TWEAK and Fn14 gene 
 expression in human SGBS adipocytes  



























































































































































































































































































































































Vendrell et al. JCEM. 2010; 95:2983-92 
Infammation + Hypoxia 
Infammatory 
stimulus 






















































1%O2 21%O2 TNFα HUVEC
TWEAK




Hypoxia and inflammation on TWEAK  and Fn14 protein expression in human 
SGBS adipocytes  
THP-1 
Human Monocytes 
Macrophage differentiation is associated with a reduction in the 
nucleocytoplasmic ratio due to an increase in cytoplasmic volume 
Increasing numbers of lysosomes and mitochondria with 
macrophage differentiation 
Study the  of hypoxia, inflammation and ER stress on TWEAK and Fn14 gene  
expression in THP-1 human macrophages 
Study the  of hypoxia, inflammation and ER stress on TWEAK and Fn14 gene  








































































































































































































Vendrell et al. JCEM. 2010; 95:2983-92 
 Adipose Tissue  of severely obese subjects have altered expression levels 
 of Hypoxia  and ER stress genes  
Hypoxia, ER and inflammatory stimuli strongly increases IL-6 levels 
in adipocytes and macrophages 











































































Human SGBS adipocytes 
           
Human THP-1 macrophages 
















































Vendrell et al. JCEM. 2010; 95:2983-92 










































































































































































































































































































































































































Vendrell et al. JCEM. 2010; 95:2983-92 
 
TWEAK/Fn14 is expressed in SAT and VAT tissue 
TWEAK acts  as a pro-inflammatory cytokine in human adipocyte cells 
 We report an over expression of TWEAK/Fn14, hypoxia and ER  
characteristic genes in both SAT and VAT adipose tissue depots of 
severely obese patients 
However both TWEAK and Fn14 genes were neither hypoxia nor ER 
stress sensitive but inflammation regulated 
The increment of TWEAK and Fn14 expression in severe obesity may 
be due to the inflammatory environment, in particular that caused by the 















IL-6, MCP-1, IL-8 
MODEL OF ACTION OF TWEAK-Fn14 IN ADIPOSE TISSUE 
macrophage 









1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
* 
Could fluctuations in circulating Tweak  have an impact on TNFα-induced 
inflammatory response? 
 
How the adipocyte responds in an environment  where Tweak and TNFα 
are present? 
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Tweak signaling TNFα signaling 
A) 






unprimed Tweak  primed
Adipocyte Tweak priming reduced TRAF2 protein levels 
Mature human SGBS  adipocytes 
Conclusion 
 
Our observation of lower Tweak circulating levels in severely obese subjects 
could indicate that these subjects are prone to having a more potent 
inflammatory TNFα outcome  
 
Tweak modulates IL-6, IL-8 and Adiponectin production induced by TNFα  
in adipocytes 

















IL-6, L-8, AdipoQ 
Hypothesis for the mechanism of interaction between Tweak and TNFα 
CIBERDEM 








Eduardo Garcia- Fuentes 
José Manuel Fernández Real 
 
Enric Caubet 
Nuria Vilarrasa 
Antonio García-España 
